FDA Inspection 774914 — Cumberland Pharmaceuticals, Inc.
The FDA completed an inspection of Cumberland Pharmaceuticals, Inc. on April 4, 2012 in Nashville, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 4, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nashville, TN (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)